Amit Bhanvadia, MD
Gastroenterology · Anaheim, CANPI 1861751083
Payments from drug & device makers
Across 705 payments — averaging $2386.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$666K
- Boehringer Ingelheim International GmbH$323K
- AstraZeneca$240K
- Regeneron$149K
- Bausch Health US, LLC$105K
- Bristol Myers Squibb$76K
- plus $123K from 25 others
Across 3 payments — averaging $5549.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$16K
- Eli Lilly$388
What the payments were for
- Food & beverage$5,476100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 197 | $666,261 |
| Boehringer Ingelheim International GmbH | 122 | $322,922 |
| AstraZeneca | 7 | $240,109 |
| Regeneron | 71 | $149,251 |
| Bausch Health US, LLC | 33 | $104,729 |
| Bristol Myers Squibb | 33 | $76,478 |
| AbbVie | 66 | $57,378 |
| Eli Lilly | 1 | $29,900 |
| E.r. Squibb & Sons, L.L.C. | 3 | $16,220 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $15,981 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 36 | $683 |
| Gilead | 22 | $571 |
| Conmed Corporation | 1 | $351 |
| Pfizer | 16 | $335 |
| Johnson & Johnson | 10 | $253 |
| Redhill Biopharma Inc. | 12 | $229 |
| QOL Medical, LLC | 9 | $177 |
| Ardelyx, Inc. | 6 | $135 |
| Intercept Pharmaceuticals, Inc. | 6 | $122 |
| Nestle Healthcare Nutrition Inc. | 6 | $121 |
| Sanofi | 4 | $105 |
| Ironwood Pharmaceuticals, Inc | 5 | $94 |
| Enterra Medical, Inc. | 1 | $58 |
| Boston Scientific | 1 | $39 |
| Braintree Laboratories, Inc. | 2 | $36 |
| Lilly USA, LLC | 1 | $26 |
| Shire North American Group Inc | 1 | $25 |
| Celltrion USA Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Evoke Pharma, Inc. | 1 | $15 |
| Intra-sana Laboratories | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CONMED BILIARY$351
- CONMED HEMOSTASIS$351
- CONMED GENERATORS$351
- Epclusa$112
How this compares
$1,682,658 in reported general payments places this provider in the 95th percentile of 1,885 gastroenterology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 17 | $287 |
| Famotidine | 13 | $67 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Anaheim
- Peter WinkleCypress$116.7M
- Manuchehr DaraniSanta Ana$17.7M
- Jatinder PruthiLancaster$4.4M
- Long DangWestminster$4.3M
- Muhammad SheikhFresno$4.3M
- Gregory WienerChula Vista$3.5M
- Gil MelmedLos Angeles$3M
- Christopher BowlusSacramento$3M
- Bennett RothLos Angeles$2.8M
- Brigid BolandSan Diego$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.